COVID-19Pneumonia and its Mortality rates in Afghanistan; A Cross-sectional Study 2021-2022

Authors

  • Razia Miri Pharm D, Instructor of Paraclinic department, Pharmacy Faculty, Cheragh Medical Institute of Higher Education, Kabul, Afghanistan
  • Sughra Alizada Pharm D, Hospital Pharmacist, Kabul, Afghanistan
  • Zahra Alizada Medical Technologist, Kabul, Afghanistan
  • Zahra Shafaee Pharm D, Clinical Pharmacist, Kabul. Afghanistan
  • Abdullah Rezaie Pharm D, Clinical Pharmacist, Kabul. Afghanistan

Keywords:

Pneumonia COVID-19, Mortality rates and Kabul

Abstract

Corona virus is considered one of the dangerous viruses of the last decade, which has caused challenges to human life in different dimensions with its rapid spread. This virus causes an increase in the number of deaths among patients by causing pneumonia. Aim and method: The aim of this study is to investigate the mortality rates of covid-19 patients with pneumonia, the required data of which was collected from the AfghanJapan hospital in six months between 2021 and 2022. Results: In this study, information was collected from 229 patients with COVID-19 pneumonia, of which 135 patients recovered but 94 patients died. Although the majority of variables studied in this research are similar between deceased and recovered patients, the blood oxygen level and breathing rate of deceased and recovered patients are different. Conclusion: The presence of pneumonia in patients with COVID-19 causes the deterioration of the patient's condition and even causes the patient's death.

Downloads

Published

2023-04-26

How to Cite

Razia Miri, Sughra Alizada, Zahra Alizada, Zahra Shafaee, & Abdullah Rezaie. (2023). COVID-19Pneumonia and its Mortality rates in Afghanistan; A Cross-sectional Study 2021-2022. Zeta Repository, 19, 184–193. Retrieved from https://zetarepo.com/index.php/zr/article/view/1999

Issue

Vol. 19 (2023): EMRP

Section

Articles